
RIP to These 3 Dying Medical Stocks
Published on April 10, 2023
Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before...
